Join the COVID-19 group to help and get support from people like you.
COVID-19 News (Page 9)
Related terms: 2019-nCoV, 2019 Novel Coronavirus, Coronavirus, SARS-CoV-2 Infection, Novel Coronavirus Pneumonia
Mild Initial Clinical Course Seen for COVID-19 Vaccine-Linked Myocarditis
THURSDAY, Sept. 19, 2024 – COVID-19 vaccine-associated myocarditis (C-VAM) has a mild initial clinical course, but myocardial injury is common, according to a study published online in the October...
Metformin Use Tied to Lower Incidence of Death, Long COVID After COVID-19
THURSDAY, Sept. 19, 2024 – After severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, prevalent metformin use is associated with a slightly lower incidence of death or postacute...
Diabetes Med Metformin Could Cut Risks for Long COVID
THURSDAY, Sept. 19, 2024 – One of the most common diabetes drugs, metformin, might deliver an added bonus: Lowering users' odds for Long COVID. Long COVID can present with symptoms including chronic...
Expert Advice on Preparing for the Fall COVID, Flu Season
MONDAY, Sept. 16, 2024 – People should prepare for the fall cold and flu season by getting the updated influenza and COVID-19 vaccinations, an infectious diseases expert says. “When my patients ask m...
Many Americans Wary of Vaccines as Fall Flu, COVID Season Looms: Survey
THURSDAY, Sept. 12, 2024 – A lot of Americans are on the fence regarding annual flu and COVID shots, a new survey finds. More than one-third of those polled (37%) said they’d gotten vaccines in the p...
Pandemic Isolation May Have Caused Rapid Brain Aging in Teen Girls
TUESDAY, Sept. 10, 2024 – New research uncovers a possible reason why teenaged girls struggled so mightily with their mental health during the pandemic: Scans showed their brains aged far faster...
Caseload Strain Linked to Patient Survival During Delta Wave of COVID-19
TUESDAY, Sept. 10, 2024 – Across hospital types, there is a comparably detrimental relationship between COVID-19 caseload and patient survival, according to a study published online Sept. 10 in the...
Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.
GAITHERSBURG, Md., Aug. 30, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced the Novavax COVID-19 Vac...
Demographic Factors Tied to Differences in Long COVID Symptoms
FRIDAY, Aug. 30, 2024 – Demographic factors significantly influence long COVID symptom severity, according to a study published online Aug. 28 in JRSM Open. David Sunkersing, Ph.D., from University ...
Fewer Complications at 18 Months Seen With Post-COVID-19 Vaccination Myocarditis
THURSDAY, Aug. 29, 2024 – Patients with post-COVID-19 mRNA vaccination myocarditis show a lower frequency of cardiovascular complications than those with conventional myocarditis or post-COVID-19...
Pandemic Tied to Changes in Youth Mental Health
THURSDAY, Aug. 29, 2024 – The early years of the COVID-19 pandemic were associated with minor, mostly positive changes in youth mental health overall, according to a study published online Aug. 26...
Mediterranean Diet Adherence May Protect Against COVID-19
WEDNESDAY, Aug. 28, 2024 – High adherence to the Mediterranean diet may protect against COVID-19, with unclear benefits for symptoms and severity, according to a review published online Aug. 21...
U.S. Will Offer Free COVID Tests By Mail by Late September
MONDAY, Aug. 26, 2024 – As a summer surge in COVID cases begins to ebb and Americans brace themselves for yet another wave of infections this winter, more free COVID tests will soon be available to...
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine Targeting KP.2 Variant of SARS-CoV-2
CAMBRIDGE, MA / ACCESSWIRE / AUGUST 22, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application...
Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
NEW YORK & MAINZ, Germany--(BUSINESS WIRE) August 22, 2024 – Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the U.S. Food and Drug Administration (“...